Threo-DL-β-Hydroxynorleucine is a threonine-like, non-proteinogenic β-hydroxy amino acid derivative featuring a straight-chain norleucine backbone with a β-hydroxyl substituent on the side chain. The molecule contains a free amino group and a free carboxyl group, and its "threo-DL" designation indicates a threo diastereomeric relationship with a racemic (DL) stereochemical composition at the relevant stereocenter(s). As a β-hydroxy amino acid, it is used in peptide and peptidomimetic synthesis and structure-activity studies where introduction of a side-chain hydroxyl enables hydrogen-bonding interactions and provides a functional handle for further derivatization or analytical characterization.
CAT No: CP07201
1. Cationic cell-penetrating peptides are potent furin inhibitors
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More